Tozaro
Tozaro is developing a novel suite of reagents to support development and manufacture of viral vectors in cell and gene therapy. We see viral vectors through a different lens that allows us to approach common applications such as quantification of viral titer or capture chromatography in a completely different way. We believe the industry needs better tools to help realize the potential of cell and gene therapy.
The Exchange Building
Colworth Park, Sharnbrook
Bedford, MK44 1LQ
Colworth Park, Sharnbrook
Bedford, MK44 1LQ
NEWS
The Future of Cell and Gene Therapy: Navigating Innovation, Regulation, and Manufacturing Challenges
An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), reveals both promising developments and significant concerns shaping the advanced therapies sector’s trajectory through 2025 and beyond. This interview was conducted with support from Tozaro.
JOBS
IN THE PRESS